Abstract:Increasing evidence has shown that stromal interaction molecule 1 (STIM1), a key subunit of store-operated Ca2+ entry (SOCE), is closely associated with tumor growth, development, and metastasis. However, there is no report of a comprehensive assessment of STIM1 in pan-cancer. This study aimed to perform a general analysis of STIM1 in human tumors, including its molecular characteristics, functional mechanisms, clinical significance, and immune infiltrates correlation based on pan-cancer data from The Cancer Genome Atlas (TCGA). Gene expression analysis was investigated using TCGA RNA-seq data, the Tumor Immune Estimation Resource (TIMER). Phosphorylation analysis was undertaken using the Clinical Proteomic Tumor Analysis Consortium (CP-TAC) and the PhosphoNET database. Genetic alterations of STIM1 were analyzed using cBioPortal. Prognostic analysis was via the R package "survival" function and the Kaplan-Meier plotter. Functional enrichment analysis was via by the R package "cluster Profiler" function. The association between STIM1 and tumor-infiltrating immune cells and immune markers was by the R package "GSVA" function and TIMER. STIM1 was differentially expressed and associated with distinct clinical stages in multiple tumors. The phosphorylation of STIM1 at S673 is highly expressed in clear cell renal carcinoma and lung adenocarcinoma tumors compared to normal tissues. STIM1 genetic alterations correlate with poor prognosis in several tumors, including ovarian cancer and lung squamous cell carcinomas. High STIM1 expression is associated with good or poor prognosis across diverse tumors. Overall survival (OS) analysis indicated that STIM1 is a favorable prognostic factor for patients with BRCA, KIRC, LIHC, LUAD, OV, SARC, and UCEC, and is a risk prognostic factor for BLCA, KIRP, STAD, and UVM. There is a close correlation between STIM1 expression and immune cell infiltration, immune-regulated genes, chemokines, and immune checkpoints in a variety of tumors. STIM1 functions differently in diverse tumors, playing an oncogenic or antitumor role. Moreover, It may serve as a prognostic biomarker and an immunotherapy target across multiple tumors.

Suppression of STIM1 Inhibits the Migration and Invasion of Human Prostate Cancer Cells and is Associated with PI3K/Akt Signaling Inactivation

STIM1 Accelerates Cell Senescence in a Remodeled Microenvironment but Enhances the Epithelial-to-mesenchymal Transition in Prostate Cancer

Knockdown of STIM1 Expression Inhibits Non-Small-cell Lung Cancer Cell Proliferation in Vitro and in Nude Mouse Xenografts.

Suppression of Stromal Interaction Molecule 1 Inhibits SMMC7721 Hepatocellular Carcinoma Cell Proliferation by Inducing Cell Cycle Arrest.

Effect of stromal interaction molecular 1 gene on proliferation and apoptosis of prostate cancer PC-3 cells

TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination

PDLIM5 Inhibits STUB1-mediated Degradation of SMAD3 and Promotes the Migration and Invasion of Lung Cancer Cells.

Down-regulation of STIP1 Regulate Apoptosis and Invasion of Glioma Cells Via TRAP1/AKT Signaling Pathway.

STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation.

Blocking of Stromal Interaction Molecule 1 Expression Influence Cell Proliferation and Promote Cell Apoptosis in Vitro and Inhibit Tumor Growth in Vivo in Head and Neck Squamous Cell Carcinoma

[Stromal Interaction Molecule 1 Silencing Attenuates the Proliferation and Migration Capacities of Endothelial Progenitor Cells].

Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors.

Stromal Interaction Molecule 1 (STIM1) Knock Down Attenuates Invasion and Proliferation and Enhances the Expression of Thyroid-Specific Proteins in Human Follicular Thyroid Cancer Cells.

STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma

STK10 Knockout Inhibits Cell Migration and Promotes Cell Proliferation Via Modulating the Activity of ERM and P38 MAPK in Prostate Cancer Cells.

PIM-1 Gene RNA Interference Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells and Suppresses Tumor Progression in Vivo

St6gal-I Overexpression Facilitates Prostate Cancer Progression Via The Pi3k/Akt/Gsk-3 Beta/Beta-Catenin Signaling Pathway

STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway

Knockdown of STIP1 inhibits the invasion of CD133‐positive cancer stem‐like cells of the osteosarcoma MG63 cell line via the PI3K/Akt and ERK1/2 pathways

STIM1 Overexpression in Hypoxia Microenvironment Contributes to Pancreatic Carcinoma Progression

Stromal Interaction Molecule 1/microtubule‐associated Protein 1a/1b‐light Chain 3B Complex Induces Metastasis of Hepatocellular Carcinoma by Promoting Autophagy